(NASDAQ: MASI) Masimo's forecast annual revenue growth rate of -1.48% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.7%.
Masimo's revenue in 2025 is $1,848,200,000.On average, 4 Wall Street analysts forecast MASI's revenue for 2025 to be $82,532,536,033, with the lowest MASI revenue forecast at $82,334,685,067, and the highest MASI revenue forecast at $82,699,747,804. On average, 4 Wall Street analysts forecast MASI's revenue for 2026 to be $88,852,413,037, with the lowest MASI revenue forecast at $88,196,332,282, and the highest MASI revenue forecast at $89,346,388,552.
In 2027, MASI is forecast to generate $96,221,193,511 in revenue, with the lowest revenue forecast at $95,779,532,789 and the highest revenue forecast at $96,625,913,360.